论文部分内容阅读
目的探讨欣普贝生的不良事件及处理措施。方法回顾性分析2008年1月—2010年12月笔者所在医院欣普贝生引产产妇的不良事件,随机选择150例非欣普贝生阴道试产的产妇做对照。结果欣普贝生组在急产、胎心异常、宫缩异常方面高于非欣普贝生组,非欣普贝生组转剖宫产发生率明显高于欣普贝生组。结论虽然欣普贝生有上述较多不良事件,但其促宫颈成熟作用效果良好,对提高阴道分娩率,降低剖宫产率及改善产科质量,具有重大意义。
Objective To explore the adverse events and treatment measures of Hinbebexen. Methods Retrospective analysis of January 2008 - December 2010 my hospital Xinpeisheng induction of maternal adverse events, random selection of 150 cases of non-Xin Pu Beibei vaginal trial of mothers as a control. Results The Xinpibai group was higher than the non-Xinpibai group in acute birth, abnormal fetal heart rate and abnormal uterine contractions. The incidence of cesarean section in the non-Xinpobei group was significantly higher than that in the Xinpibai group. Conclusion Although there are many adverse events mentioned above, it is of great significance to promote cervix maturation and improve vaginal delivery rate, cesarean section rate and quality of obstetrics.